Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences The Space Summit 2019

Paul Gatenholm's Biography

Paul Gatenholm, Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway

Dr. Gatenholm is professor of Biopolymer Technology at Chalmers University of Technology, Founder of 3D Bioprinting Center, and Director of Graduate School at WWSC. He is also Adjunct Professor at Joint School of Biomedical Engineering and Sciences at Virginia Tech and Wake Forest University and Adjunct Professor of Biomaterials at Wake Forest Institute for Regenerative Medicine in Winston-Salem, North Carolina, USA. His research includes biological fabrication through the use of enzymes, cells, and the coordination of biological systems. Dr. Gatenholm is particularly interested in designing and preparing new biomaterials which can replace or regenerate tissue and organs. During past five years he has dedicated his time to development of 3D Bioprinting technology which he believes will revolutionize the field of Medicine. He has published more than 300 papers and edited several books and has more than 9000 citations. He is elected member of Swedish Royal Academy of Engineering Sciences. Dr Gatenholm is an entrepreneur and is currently CEO of new biotech start up in Oslo, Norway.

Paul Gatenholm Image

3D Bioprinting of Vascular Tissue and Organs for Clinical Applications on Earth and for Space Exploration

Monday, 14 October 2019 at 17:00

Add to Calendar ▼2019-10-14 17:00:002019-10-14 18:00:00Europe/London3D Bioprinting of Vascular Tissue and Organs for Clinical Applications on Earth and for Space ExplorationThe Space Summit 2019 in Coronado Island, CaliforniaCoronado Island,

3D Bioprinting technology is rapidly developing. The initial challenges of cell survival in 3D Bioprinting process have been addressed and new generations of 3D Bioprinters and bioinks have been developed. Printed living tissues are becoming a standard tool for study of disease, drug screening and testing of cosmetics and chemical products. But no 3D bioprinted tissue has been implanted in human yet. The remaining challenge is to secure vascularization of the tissue. In our laboratory we focus on 3D Bioprinting of autologous adipose tissue which could be performed at the point of care. We have discovered remarkable in situ vascularization of 3D implanted constructs consisted of microfractured adipose and stem cells. Such vascularized tissue constructs can be used for reconstructive soft tissue surgery, wound healing and for delivery of functional cells such as beta cells to restore function of pancreas. This technology can be easy translated to clinic and utilized for Space Exploration.

Add to Calendar ▼2019-10-14 00:00:002019-10-15 00:00:00Europe/LondonThe Space Summit 2019The Space Summit 2019 in Coronado Island, CaliforniaCoronado Island,